Alkermes plc (ALKS)
Biotechnology · Healthcare · $7.5B
Intrinsic Value (Consensus)
$17.54
Current Price
$45.01
Margin of Safety
-61%
61% Above Intrinsic Value
Value: $18
Price: $45
Valuation Model Estimates
Current Price: $45.01
DCF (Discounted Cash Flow)
$25.00
Graham Number
$14.87
Earnings Power Value
$12.32
Relative Value (P/E)
$17.99
Dividend Discount Model
Not applicable
—
Consensus Value
$17.54
Model Assumptions
Discount Rate
10.3%
Growth Rate
8.6%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
57
Profitability
18/25
Strength
25/25
Valuation
7/25
Growth
7/25
Financial Health Signals
Declining revenue — top line is shrinking
Low debt — conservative balance sheet
Key Financials
- EPS (TTM)
- $0.90
- EPS (Forward)
- $0.98
- Book Value
- $10.93
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 13.3%
- Debt/Equity
- 16%
- Revenue Growth
- -5.2%
- Earnings Growth
- 8.6%
- Dividend Yield
- N/A
- Beta
- 0.26
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance